Clinical Research Partners

Richmond, Virginia 25233

1 studies enrolling now · 10 studies all time

What they study most

Atopic Dermatitis, COVID-19, Cardiovascular Disease, Celiac Disease, Food Hypersensitivity, Growth, High Cardiovascular Risk, Influenza, Human, Obesity, Overweight, Peanut Allergy, Respiratory Syncytial Virus

Studies at this site

• VTP-1000 in Adults With Celiac Disease — Recruiting now
• A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age — Completed
• A Study of mRNA-1345, an mRNA Vaccine Targeting Respiratory Syncytial Virus, in Children 2 to <18 Years of Age at High Risk of Respiratory Syncytial Virus — Completed
• Phase 2/3 Heterologous Boosting Study With Different Dose Levels of Monovalent SARS-CoV-2 rS Vaccines — Completed
• CNP-201 in Subjects With Peanut Allergy — Stopped early
• Evaluate Efficacy, PK, and Safety of FB825 in Adults With Atopic Dermatitis — Status unconfirmed
• A Clinical Trial of KT07 Capsule in the U.S.A — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Growth of Infants Fed an Extensively Hydrolyzed Infant Formula — Completed
• Elemental Formula Hypoallergenicity — Completed